Modafinil is a Schedule IV drug that enhances vigilance and memory. It is also known as a “neuro-stimulant” and has several uses. Learn more about Modafinil and how to get it online. It is safe to order from a reputable online vendor.
Modafinil is a Schedule IV drug
Modafinil is an anti-dopaminergic drug used to treat sleep disorders such as narcolepsy and shift work sleep disorder (OSAHS). This drug works to prevent excessive daytime sleepiness, which is a symptom of the disorders. It also prevents sleepiness caused by OSAHS, or obstructive sleep apnea/hypopnea syndrome, which is characterized by short, shallow breaths during sleep.
It is a neuro-stimulant
Modafinil is a neuro-stimulant that is thought to improve the functioning of certain brain regions. It increases levels of DA, 5-HT and HA in the brain. The exact mechanism of this effect remains unclear. However, it is believed to work through an upstream site of action. For instance, a study published in the journal Neuron suggests that modafinil increases the level of the dopamine transporter (DAT).
It increases vigilance
Modafinil, a derivative of the amino acid diphenylmethylsulfinyl-acetamide, has been shown to improve vigilance in several studies. Unlike other amphetamine-like psychostimulants, modafinil displays a different neurochemical profile. However, the online Modafinil order cellular mechanisms by which modafinil increases vigilance are not yet fully understood.
It improves memory
Researchers have found that the wakefulness-promoting drug modafinil can improve memory functions in people recovering from depression. Depression is one of the leading causes of disability worldwide, and cognitive symptoms are commonly associated with its severity. People with depression often experience difficulty paying attention or concentrating, and this cognitive impairment can persist even after the mood symptoms improve. This can cause poor work performance and increase the risk of relapse.
It improves reaction time
The effects of modafinil on reaction time have been well documented. This cognitive enhancer has been found to enhance single-unit and multiunit activity in the brains of rats. It has also been studied in human subjects using scalp EEG and whole-brain fMRI.
It decreases fatigue
The primary endpoint of this study was the change in FACIT-Fatigue score from baseline to day 28 of the study. The primary outcome was adjusted for baseline fatigue, performance status, and age. Secondary endpoints included safety, patient-reported measures of depression and daytime sleepiness, and quality of life.